CPT1A and metabolic dysfunction-associated steatotic liver disease: These findings suggest a close relationship between the alteration of CPT‐1 expression and development of NAFLD, although it is not possible to conclude that the increase in CPT‐1 expression is responsible for the net result of NAFLD improvement.